A multidisciplinary team at The University of Texas Medical Branch at Galveston working to combat the COVID-19 virus has a system that will unlock researchers’ ability to more quickly develop and evaluate developing vaccines, diagnose infected patients and explore whether or how the virus has evolved.

Researchers at The University of Texas Medical Branch are collaborating with the clinical trial laboratory services organization Q2 Solutions to make a new assay test available that will streamline the development of a COVID-19 vaccine.